Animal Models of T Cell-Mediated Skin Diseases
Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Zollner, T. (Editor), Renz, H. (Editor), Asadullah, K. (Editor) |
Format: | Electronic eBook |
Language: | English |
Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2005.
|
Series: | Ernst Schering Research Foundation Workshop,
50 |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Respirology
Published: (2016) -
Clinical Management of Pulmonary Disorders and Diseases
Published: (2017) -
Advances in Respiratory Cancerogenesis
Published: (2016) -
Matrix Metalloproteinases in Tissue Remodelling and Inflammation
Published: (2008) -
A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics
Published: (2010)